Quest Diagnostics 2005 Annual Report Download - page 54

Download and view the complete annual report

Please find page 54 of the 2005 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 118

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118

PART III
Item 10. Directors and Executive Officers of the Registrant
Information concerning the directors of the Company is incorporated by reference to the information in the
Proxy Statement appearing under the caption “Election of Directors’’.
Executive Officers of the Registrant
Officers of the Company are elected annually by the Board of Directors and hold office at the discretion of
the Board of Directors. The following persons serve as executive officers of the Company:
Surya N. Mohapatra, Ph.D. (56) is Chairman of the Board, President and Chief Executive Officer of the
Company. Prior to joining the Company in February 1999 as Senior Vice President and Chief Operating Officer,
he was Senior Vice President of Picker International, a worldwide leader in advanced medical imaging
technologies, where he served in various executive positions during his 18-year tenure. Dr. Mohapatra was
appointed President and Chief Operating Officer in June 1999, the Chief Executive Officer in May 2004 and
Chairman of the Board in December 2004.
W. Thomas Grant II (55) is Senior Vice President – Insurance and Employer Services. He oversees the risk
assessment and employer services businesses of the Company. Mr. Grant joined the Company in November
2005 with the acquisition of LabOne, Inc. Prior to joining the Company, Mr. Grant was the Chairman, President
and Chief Executive Officer of LabOne, Inc. from 1995 to October 2005.
Robert A. Hagemann (49) is Senior Vice President and Chief Financial Officer. He joined Corning Life
Sciences, Inc., in 1992, where he held a variety of senior financial positions before being named Vice President
and Corporate Controller of the Company in 1996. Prior to joining the Company, Mr. Hagemann was employed
by Prime Hospitality, Inc. and Crompton & Knowles, Inc. in senior financial positions. He was also previously
employed by Arthur Young, a predecessor company to Ernst & Young. Mr. Hagemann assumed his present
responsibilities in August 1998.
Robert E. Peters (58) is Vice President – Sales and Marketing. He oversees sales and marketing for our
clinical laboratory testing business. Mr. Peters joined the Company in 1997 as Managing Director of our
Teterboro laboratory, became Senior Managing Director of the New York/New Jersey region in 2000 and
Regional Vice President for the East region in 2002. Mr. Peters assumed his current position in March 2003.
Prior to joining the Company, Mr. Peters was with Ciba-Geigy Corporation, most recently serving as Vice
President of Pharmaceutical Operations.
Michael E. Prevoznik (44) is Senior Vice President and General Counsel. Prior to joining SBCL in 1994 as
its Chief Legal Compliance Officer, Mr. Prevoznik was with Dechert Price & Rhodes. In 1996, he became Vice
President and Chief Legal Compliance Officer for SmithKline Beecham Healthcare Services. In 1998, he was
appointed Vice President, Compliance for SmithKline Beecham, assuming additional responsibilities for
coordinating all compliance activities within SmithKline Beecham worldwide. Mr. Prevoznik joined the Company
as Vice President and General Counsel in August 1999. In 2003, he assumed additional responsibilities for
corporate communications and governmental affairs, and in 2004, assumed additional responsibilities relating to
the Six Sigma function.
David M. Zewe (54) is Senior Vice President, Diagnostics Testing Services. Mr. Zewe oversees diagnostic
testing operations company-wide, including physician, clinical trials and drugs of abuse testing, as well as the
diagnostic instruments business. Mr. Zewe joined the Company in 1994 as General Manager of the Philadelphia
regional laboratory, became Regional Vice President Sales and Marketing for the mid-Atlantic region in August
1996, became Vice President, Revenue Services in August 1999, leading the billing function company-wide, and
became Senior Vice President, U.S. Operations in January 2001, responsible for all core business operations and
revenue services. Mr. Zewe assumed his current position in May 2002. Prior to joining the Company, Mr. Zewe
was with the Squibb Diagnostics Division of Bristol Myers Squibb, most recently serving as Vice President of
Sales.
Item 11. Executive Compensation
The information called for by this Item is incorporated by reference to the information under the caption
“Additional Information Regarding Executive Compensation’’ appearing in the Proxy Statement.
37